March 26, 2018 / 2:30 PM / 6 months ago

BRIEF-Mimedx Reports Positive Results From Phase 2B Clinical Trial Of Amniofix Injectable

March 26 (Reuters) - Mimedx Group Inc:

* MIMEDX REPORTS POSITIVE PAIN AND FOOT FUNCTION RESULTS FROM PHASE 2B CLINICAL TRIAL OF AMNIOFIX® INJECTABLE IN THE TREATMENT OF PLANTAR FASCIITIS

* MIMEDX GROUP INC - AMNIOFIX INJECTABLE ACHIEVES PRIMARY AND SECONDARY EFFICACY ENDPOINTS

* MIMEDX GROUP INC - ‍STATISTICALLY SIGNIFICANT DIFFERENCE IN PAIN AND FUNCTION COMPARED TO PLACEBO​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below